Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 06.01.2021
Hypoport SE
Press release
Appointment
New head of B2B personal loans business in the Hypoport network
Berlin, 6 January 2021: The Hypoport Group is strengthening its sales operations in B2B personal loans and has appointed Thomas Teuber to head up Hypoport's activities in this business from February 2021.
Prior to joining Hypoport, Mr Teuber worked at [ … ]
Wed, 06.01.2021
Leonteq AG
PRESS RELEASE | LEONTEQ OPENS DUBAI OFFICE
Zurich, 06 January 2021
Leonteq AG (SIX: LEON) is expanding its presence in the Middle East with the opening of an office in Dubai to serve the GCC market.
The launch of a local presence in Dubai forms part of Leonteq's plans to expand its global footprint and represents a logical step forward in its e [ … ]
Wed, 06.01.2021
Vivoryon Therapeutics N.V.
Vivoryon Therapeutics N.V. new ISIN code
HALLE (SAALE) / MUNICH, Germany, 06 January 2021 - in connection with the conversion into an N.V., a public company under the laws of the Netherlands (naamloze vennootschap, "N.V.") which has taken effect on 28 November 2020, Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY) announces that the shares [ … ]
Tue, 05.01.2021
Aroundtown SA
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS
AROUNDTOWN PUBLISHES SUBSCRIPTION PRICE AND RATIO FOR SCRIP DIVIDEND5 January 2021
A [ … ]
Tue, 05.01.2021
ABIVAX
Abivax Publishes Review in Drug Discovery Today on Mechanism of Action and Transformative Potential of ABX464 as Therapy for Inflammatory Diseases
Scientific review summarizes the molecular events leading to potent anti-inflammatory effects of lead molecule ABX464, centered around the specific upregulation of microRNA-124 (miR-124)
Scientific dat [ … ]
Tue, 05.01.2021
asknet Solutions AG
asknet Solutions AG entered discussions with strategic partner
January 5, 2021, Karlsruhe - asknet Solutions AG (Ticker symbol: ASKN, ISIN: DE000A2E3707, WKN: A2E370) herewith announces that it entered discussions with a strategic investor regarding a potential business partnership and an equity participation. As part of the strategic partnership, [ … ]
Tue, 05.01.2021
TubeSolar AG
TubeSolar AG: Contract signed for investment in US company Ascent Solar Technologies, Inc.
Augsburg, Germany, January 5, 2021: TubeSolar AG (ISIN DE000A2PXQD4, XETRA, primary market Düsseldorf, m:access) today closed the announced agreement on the strategic investment in Ascent Solar Technologies, Inc. (OTC market "AscentSolar", ticker symbol: AST [ … ]
Tue, 05.01.2021
BP p.l.c.
BP p.l.c.
Total voting rights and share capital
As at 31 December 2020, the issued share capital of BP p.l.c. comprised 20,344,625,660 ordinary shares (excluding treasury shares) par value US$0.25 per share, each with one vote; and 12,706,252 preference shares par value £1 per share with two votes for every £5 in nominal capital held.
The number of [ … ]
Tue, 05.01.2021
Capcora GmbH
SUNfarming achieved closing on the first tranche under a framework term loan and VAT facility in an amount of approx. PLN 116m provided by ING Bank Śląski S.A. The 15 years non-recourse loan is dedicated to refinance a portfolio of CfD awarded solar PV projects with 26 MWp in Poland. Financial close on the first tranche in an amount of PLN 45m was [ … ]
Tue, 05.01.2021
Immunic, Inc.
Immunic, Inc. to Participate in Investor Conferences in January
- Management Provides Update on Timing of Data for IMU-838 in Primary Sclerosing Cholangitis -NEW YORK, January 5, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inf [ … ]